Michael C
Vice President Finance at XyloCor Therapeutics, Inc. | Furlong, Pennsylvania, United States
Engage
candidates 10x faster
Enjoy unlimited access and discover candidates outside of LinkedIn
Trusted by 1.4M users from 76% of Fortune 500 companies
The most accurate data ever
CCPA Compliant
GDPR Compliant
150M
Personal Emails
200M
Work Emails
100M
Direct Dials
250M
Professional Profiles
40M
Company Profiles
Find anyone, anywhere
with ContactOut
today
Making remote or global hires?
Connecting
with key decision-makers? We can help.
- 40 emails / month
- 3 phone numbers / month
- Works on standard LinkedIn only
-
Work emails, personal emails,
mobile numbers
No credit card required
As the Vice President of Finance at XyloCor Therapeutics, Inc., Michael C. plays a pivotal role in shaping the financial landscape of a cutting-edge clinical-stage gene therapy company. With a robust background in financial performance management and growth, he is instrumental in stabilizing and advancing the company's finance, accounting, and audit processes. Michael's expertise in turnaround strategy and startup acceleration is particularly valuable in the dynamic environment of life sciences, where rapid adaptation and strategic funding are crucial for success.
In his current role, Michael partners closely with the CEO to spearhead fundraising initiatives, having recently executed an oversubscribed Series A extension that significantly broadened the company's investor syndicate. This achievement not only underscores his proficiency in investor relations but also highlights his ability to navigate complex financial landscapes to secure vital capital for innovative projects. His strategic oversight extends to international partnerships and treasury operations, ensuring that XyloCor is well-positioned for sustainable growth.
Michael's comprehensive skill set encompasses financial audits, business analysis, and cash flow management, all of which are essential for maintaining compliance with the Sarbanes-Oxley Act and other regulatory requirements. His collaborative working style fosters a culture of transparency and accountability within the finance team, while his adeptness in system implementations and report generation enhances operational efficiency. As XyloCor Therapeutics continues to advance its mission of developing transformative gene therapies, Michael C. remains a key driver of financial strategy and organizational re-design, positioning the company for long-term success in the competitive biotech landscape.
Vice President Finance at XyloCor Therapeutics, Inc. in December 2019 to Present
Global Controller: Interim Contractor, Medical Division at Smiths Medical in April 2019 to December 2019
Director Financial Planning and Analysis and Investor Relations at Neuronetics, Inc. in January 2015 to April 2019
Program Manager – Sarbanes-Oxley Program at Abbott in January 2013 to January 2015
Manager Financial Planning & Analysis, Commercial Operations at Abbott in January 2008 to January 2013
Senior Financial Auditor at Abbott in January 2006 to January 2008
Manager, Risk Performance Services at Crowe Horwath LLP in January 2004 to January 2006
Senior Accountant, Consumer Services Group at Crowe Horwath LLP in January 2002 to January 2004
Senior Accountant at Deloitte in January 2001 to January 2002
Associate Accountant at Deloitte in January 1999 to January 2001
See more
See less
Financial Analysis
Internal Controls
Cross-functional Team Leadership
Sarbanes-Oxley Act
Process Improvement
Financial Reporting
Budgets
Accounting
Budgeting
GAAP
Planning
Variance Analysis
Business Process Improvement
Corporate Finance
Life Sciences
Financial Audits
Business Strategy
Revenue Recognition
Sales Operations
U.S. Generally Accepted Accounting Principles (GAAP)
Business Analysis
Cash Flow
Financial Modeling
Strategic Planning
Private Equity
Leadership
Negotiation
People Management
Executive Management
Collaborative Working
Cost Savings
Persuasion
Profit & Loss Management
Strategic Forecasting
System Implementations
Business Analysis Planning & Monitoring
COSO
Month End Close
Leading Cross Functional Teams
Procube
Short-Term Forecasting
Long-Term Forecasting
Latest Best Estimates
Report Generation
Commercial Finance
Venture Debt
See more
See less
Discover more about XyloCor Therapeutics, Inc.What is Michael C email address?
Email Michael C at [email protected]. This email is the most updated Michael C email found in 2026.
How to contact Michael C?
To contact Michael C send an email to [email protected]. (updated on October 30, 2024)
What company does Michael C work for?
Michael C works for XyloCor Therapeutics, Inc.
What is Michael C's role at XyloCor Therapeutics, Inc.?
Michael C is Vice President Finance
What is Michael C's Phone Number?
Michael C's phone (215) ***-*265
What industry does Michael C work in?
Michael C works in the Research Services industry.
Michael C Email Addresses
Michael C Phone Numbers
looking for?
Find personal and work emails for over 250M professionals.
People like Michael C
Director Business Development at IU Health
Customer Support Manager at Leonardo
Regional Sales Manager at Solventum
Western Michigan Representative at Landscape Forms
Senior Buyer at OPmobility (HBPO NA) thru LHH/Adecco
Quality Control Manager at Ross Group
Senior Software Engineer at Google
Credit Risk Manager at Synovus
Co-Founder at Giorgetti, LLC
Technical Pre-Sales Consultant at Vizrt
Customer Success Manager at Barn2Door, Inc.
Owner at McDevitt Family Law
Financial Services Representative at South State Bank
Owner & Certified Personal Trainer at Lisa Jennings Rock Star Fitness
Emergency Management Coordinator at ITR Concession Company LLC
Senior Director, Public Relations and Communications at Tivity Health
Associate Financial Advisor at Edward Jones
Staff Data Scientist at KoBold Metals
Director, Global Strategy & Upstream Marketing at Cerapedics Inc.
Marketing Communication Consultant at BC Connections
Show more
Show less